Skip to main page content

• HOME
• Current Issue
• Archive
• Alerts
• About ASM
• Contact us
• Tech Support
• Journals.ASM.org

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Durand-Joly, I. Articles by Dei-Cas, E. Search for Related Content PubMed PubMed Citation Articles by Durand-Joly, I. Articles by Dei-Cas, E.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, May 2002, p. 1862-1865, Vol. 40, No. 5
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.5.1862-1865.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Pneumocystis carinii f. sp. hominis Is Not Infectious for SCID mice

Isabelle Durand-Joly,^1,2* El Moukhtar Aliouat,^1,3 Céline Recourt,¹ Karine Guyot,¹ Nadine François,² Michèle Wauquier,² Daniel Camus,^1,2 and Eduardo Dei-Cas^1,2

Ecologie du Parasitisme, Institut Pasteur de Lille, BP 245, 59019 Lille,¹ Parasitologie-Mycologie, Faculté de Médecine et Centre Hospitalier Régional et Universitaire de Lille, 59045 Lille,² Laboratoire de Parasitologie, Faculté de Pharmacie, BP 83, 59006 Lille, France³

Received 12 November 2001/ Returned for modification 8 January 2002/ Accepted 25 February 2002

Top Abstract Text References

 
The infectious power of Pneumocystis carinii f. sp. hominis was explored by inoculating SCID mice intranasally with either P. carinii f. sp. hominis or P. carinii f. sp. muris isolates. Only mice inoculated with mouse parasites developed Pneumocystis pneumonia, as assessed by microscopy and PCR. These results suggest that humans do not contract pneumocystosis from animals.

Top Abstract Text References

 
The expression "Pneumocystis carinii" describes a group of formae speciales (6) which may be distinguished by a cluster of host species-related genomic and phenotypic differences, including morphology (22) and selective infectivity to hosts of a given species (10, 15, 21, 26). Cross-infection experiments confirmed that Pneumocystis from a given mammal could not infect other host species (2, 3, 19, 20). The tested Pneumocystis sp. strains, mostly from laboratory mammals, were strongly host species specific (Table 1).

View this table: [in this window] [in a new window]

TABLE 1. Host species specificity of Pneumocystis formae speciales as revealed by cross-infection experiments

Previous attempts to infect animals with parasites from humans were often performed by using recipient hosts latently infected with Pneumocystis (8, 9). In addition, molecular tools to identify accurately the parasite isolates were not available in the oldest studies (18, 23, 27, 28). Different results in terms of the infection route were reported (27, 28). Defined cryopreservation methods applied to Pneumocystis (16) and significant improvements in available in vitro systems (4, 5) make it possible to isolate viable human-derived Pneumocystis organisms. In the present work, the infectious power of cryopreserved human Pneumocystis samples to the SCID mouse, a highly susceptible Pneumocystis animal model, was evaluated.

Pneumocystis isolates. Pneumocystis isolates were obtained from bronchoalveolar lavage fluid samples from five human immunodeficiency virus-negative patients with Pneumocystis carinii pneumonia (PCP). Mouse-derived parasites were used in order to verify the susceptibility of SCID mice to Pneumocystis nasal inoculation. P. carinii organisms were obtained from corticosteroid-treated BALB/c/BU mice (Lille Pasteur Institute, Lille, France), and parasite extraction was performed as previously described (2). Parasite isolates were identified as Pneumocystis carinii f. sp. hominis or P. carinii f. sp. muris by PCR amplification of the mitochondrial gene encoding the large subunit rRNA with primers pAZ102-H and pAZ102-E (25) and direct sequencing. When no amplification product was visualized on agarose gels, hybridization of PCR products was performed with two oligonucleotide probes, one specific to P. carinii f. sp. hominis (IPL-H) (17) and the other specific to P. carinii f. sp. muris (IPL-M). Probes for human- or mouse-derived P. carinii were, respectively, as follows: 5'-AACTATTTCTTAAAATAAATAATC-3' (IPL-H) and 5'-CGTAATTTGAATTACAAGAAGGGA-3' (IPL-M). They were synthesized and 5'-end labeled with digoxigenin obtained from Eurogentec (Seraing, Belgium). The membranes were incubated with the probes for at least 4 h, at either 42°C (IPL-H) or 55°C (IPL-M). The IPL-H probe is highly specific to P. carinii f. sp. hominis and has been used for a considerable time in our laboratory (17). The absence of cross-reactivity of the IPL-M probe was tested in the present work. Parasite samples from human or mouse origin were cryopreserved in liquid nitrogen for less than 1 year or 6 years, respectively (16). The selected cryopreservation method has proved to be efficient in obtaining viable, infectious, and ultrastructurally well-preserved Pneumocystis parasites (16).

Experimental design. P. carinii-free 7-week-old CB17 SCID mice from a colony bred at the Pasteur Institute of Lille were used as recipient hosts. Microscopy and molecular methods confirmed the absence of latent Pneumocystis infection. Recipient SCID mice were anesthetized and then intranasally inoculated with parasites suspended in 25 µl of Dulbecco's modified Eagle's culture medium (2, 11). They were divided into eight groups of three SCID mice each that were housed in separated cages. All groups were administered dexamethasone at 2 mg/ml in drinking water from 15 days before inoculation to the end of the experiment (11). Mice in groups 1 to 5 were inoculated with 10⁵ to 10⁶ P. carinii f. sp. hominis organisms per animal; organisms were obtained from PCP cases 1 to 5, respectively. Mice in groups 6 and 7 were inoculated with 10⁵ and 10⁶ P. carinii f. sp. muris organisms per animal, respectively. Group 8 consisted of uninfected SCID mice used as negative controls. Until day 21 postinfection, all mice were administered enrofloxacine (125 mg/ml in drinking water) and fluconazole (65 µg/ml in drinking water) in order to preclude development of other infections potentially present in the inoculum. All experiments were performed in separate HEPA-filtered air isolators. Ten weeks postinfection, all SCID mice were euthanized and lungs were removed for microscopic and Pneumocystis PCR analysis. Both parasite inocula and lung samples were stained with toluidine blue O, which stains cystic forms, and methanol-Giemsa, which stains cytoplasm and nuclear structures of all Pneumocystis stages, as previously described (1). Animal experiments were performed according to the conditions stipulated in European guidelines (7).

Short-term culture of human-derived Pneumocystis isolates. In order to further evaluate the growth ability of cryopreserved human-derived Pneumocystis samples, isolates 1 to 4 were cultivated on L2 monolayer lung epithelial-like cells of rat origin (ATCC CCL 149) in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum as previously described (4, 16), with some modifications. Briefly, cultures were made in quadruplicate on glass coverslips placed in the wells of 24-well flat-bottom plates. Plates were incubated for 96 h (37°C; 5% CO₂). Every 24 h, one microculture per cultured isolate was stopped in order to assess parasite development. Coverslips were washed to eliminate unattached parasites. The attached Pneumocystis organisms were detected microscopically by using methanol-Giemsa stain. As P. carinii f. sp. hominis organisms cluster closely in cultures, counting individual parasites is usually difficult. For this reason, in order to evaluate the in vitro growth of P. carinii f. sp. hominis isolates, parasite clusters were enumerated at low magnification.

Human-derived isolates 1 to 4 showed detectable in vitro development, and no morphological alteration was observed at the photonic microscopic level (Fig. 1). The number of parasite clusters increased from about 5 to 24 per coverslip within the 24 to 48 h, reaching the stationary phase by day 3. Vegetative and cystic forms, including mature cysts containing well-visible intracystic bodies, were clearly observed (Fig. 1).

View larger version (115K): [in this window] [in a new window]

FIG. 1. In vivo and in vitro P. carinii f. sp. hominis organisms. (a and b) Parasites in a fresh bronchoalveolar lavage fluid sample stained with ortho-toluidine blue (a) or methanol-Giemsa (b) stains. (c and d) Clustered vegetative and cystic forms attached to L2 epithelial alveolar cells in short-term culture after 24 h (c) or 48 h (d). Arrows, Pneumocystis cysts containing well-visible intracystic bodies; arrowheads, trophozoites. Bar, 10 µm.

Ten weeks postinfection, no parasite was detected by microscopy in lung samples from SCID mice inoculated with human-derived Pneumocystis (groups 1 to 5). All SCID mice infected with P. carinii f. sp. muris samples developed PCP (groups 6 and 7) (Table 2). No apparent clinical changes were observed in SCID mice inoculated with human or mouse Pneumocystis isolates during the experiment. PCR was only positive in lung samples from mice inoculated with P. carinii f. sp. muris (groups 6 and 7). Direct sequencing and hybridization with the IPL-M probe identified P. carinii f. sp. muris. PCRs with IPL-H- or IPL-M probe hybridizations were negative in lung samples from SCID mice inoculated with P. carinii f. sp. hominis (groups 1 to 5). No parasite was detected in control mice (group 8) with microscopy or a PCR-hybridization assay (Fig. 2).

View this table: [in this window] [in a new window]

TABLE 2. Results of cross-infection experiments with P. carinii

View larger version (70K): [in this window] [in a new window]

FIG. 2. Hybridization of amplified DNA with the digoxigenin-labeled 24-bp specific probe for P. carinii f. sp. muris (IPL-M) (top) and P. carinii f. sp. hominis (IPL-H) (bottom), defined in the mitochondrial gene encoding the large subunit rRNA. Lanes 1 to 3, control SCID mice (group 8); lanes 4 to 9, mice inoculated with P. carinii f. sp. hominis; lane 10, PCR negative control (with no added DNA); lane 11, DNA ladder; lanes 12 and 13, mice inoculated with P. carinii f. sp. muris; lane 14, P. carinii f. sp. muris organisms used as inoculum for mice from groups 6 and 7; lane 15, positive DNA control of P. carinii f. sp. hominis. The arrow indicates the size (350 bp) of the specific amplified product.

The present work provides the first evidence of the inability of viable P. carinii f. sp. hominis to develop in Pneumocystis-free SCID mice. In 1992 it was reported that human-derived Pneumocystis could develop in SCID mice latently infected with Pneumocystis (23). After nasal inoculation with human-derived Pneumocystis, mice developed PCP caused both by mouse-derived and human-derived Pneumocystis organisms. This result appeared to contradict cross-infection experiments performed using non-human-derived parasites (2, 3, 19, 20). However both models and technical approaches were different for the following reasons: (i) recipient SCID mice were latently infected with mouse-derived parasites; and (ii) detection and identification of parasites in mouse lungs were performed by using fluorescent monoclonal antibodies (23). A previous infection might also induce changes in the alveolar environment, rendering it receptive to Pneumocystis organisms from other host species. Two different groups (20; E. M. Aliouat et al., unpublished data), have previously tested this hypothesis and were unable to confirm Sethi's (23) observations. In these experiments, Pneumocystis-infected recipient hosts were inoculated with unspecific parasites, i.e., parasites derived from another host species; PCR and hybridization were used in order to identify strains on completion of the experiments. Only specific Pneumocystis organisms, i.e., the strain specific to recipient hosts, were found in their lungs (20) (Aliouat et al., unpublished data). These data suggest that coinfection with two Pneumocystis strains does not influence the host species specificity. More recently, human-derived Pneumocystis organisms were found to be unable to develop in corticosteroid-treated rats which were latently infected with rat Pneumocystis isolates and intratracheally inoculated with parasites obtained from four AIDS patients (8). In another experiment, human-derived Pneumocystis organisms were inoculated by the endotracheal route into corticosteroid-treated owl monkeys (9). Thirty weeks later, animals were euthanized and parasites were found in their lungs. The dihydropteroate synthase gene sequence found in the lung parasites showed close similarity with that of inoculated human-derived Pneumocystis isolates but, of note, the two sequences were not identical (9).

In this study, we established experimentally that the cryopreservation method (16) kept intact P. carinii f. sp. muris infectivity for at least 6 years. The same method was used for human-derived isolates that were stored in liquid nitrogen for less than 1 year. Viability and infectivity of human Pneumocystis isolates were proved by the fact that isolates showed significant growth when cultured on L2 monolayer alveolar epithelial cells.

Our results are consistent with the following facts. P. carinii f. sp. hominis has not been found in animals until now (17). P. carinii f. sp. hominis is the unique forma specialis that we have identified in humans after more than 5 years of routine molecular laboratory diagnosis of PCP. As expected on the basis of recent phylogenetic studies (13, 15), parasites of human origin were not infectious to SCID mice. These observations suggest that humans do not contract PCP from infected animals and that pneumocystosis should not have a zoonotic pattern. Consistently, more and more evidence supports the hypothesis that humans play a key role in the circulation of parasites in the community (14), representing probably the most important infection source for susceptible human subjects (12, 24).

 
We thank Sergio Vargas from the Santiago University (Chile) for fruitful discussion and Jean-Pierre Gazet from the Lille Pasteur Institute for technical assistance.

This work was supported by the European Commission (5th-FRTD, Eurocarinii; QLK2-CT-2000-01369), the French Ministry of Research and Education ("Pneumocystis"-PRFMMIP network), and the National Agency for AIDS Research. This research was developed in the framework of the Institut Fédératif de Recherche (IFR17-Lille Pasteur Institute).

 
* Corresponding author. Mailing address: Ecology of Parasitism, Institute Pasteur of Lille, 1 rue du Prof-Calmette-BP245, 59019 Lille, France. Phone: 33 3 20 87 71 55. Fax: 33 3 20 87 79 08 or 33 3 20 44 42 64. E-mail: isabelle.joly{at}pasteur-lille.fr.

Top Abstract Text References

 

1
1. Aliouat, E. M., E. Dei-Cas, M. A. Ouaissi, F. Palluault, B. Soulez, and D. Camus. 1993. In vitro attachment of Pneumocystis carinii from mouse and rat origin. Biol. Cell 77:209-217.[CrossRef][Medline]
2
2. Aliouat, E. M., E. Mazars, E. Dei-Cas, J. Y. Cesbron, and D. Camus. 1993. Intranasal inoculation of mouse, rat or rabbit-derived Pneumocystis in SCID mice. J. Protozool. Res. 3:94-98.
3
3. Aliouat, E. M., E. Mazars, E. Dei-Cas, P. Delcourt, P. Billaut, and D. Camus. 1994. Pneumocystis cross infection experiments using SCID mice and nude rats as recipient host, showed strong host-species specificity. J. Eukaryot. Microbiol. 41(Suppl.):71.[Medline]
4
4. Aliouat, E. M., E. Dei-Cas, P. Billaut, L. Dujardin, and D. Camus. 1995. Pneumocystis carinii organisms from in vitro culture are highly infectious to the nude rat. Parasitol. Res. 81:82-85.[CrossRef][Medline]
5
5. Aliouat, E. M., L. Dujardin, A. Martínez, T. Duriez, and E. Dei-Cas. 1999. Pneumocystis carinii growth kinetics in culture systems and in hosts: involvement of each life cycle parasite stage. J. Eukaryot. Microbiol. 46(Suppl.):116-117.[Medline]
6
6. Anonymous. 1994. Revised nomenclature for Pneumocystis carinii. The Pneumocystis Workshop. J. Eukaryot. Microbiol. 41(Suppl.):121-122.
7
7. Anonymous. 1986. Council directives on the protection of animals for experimental and other scientific purposes. J. Off. Communautés Européennes, 86/609/EEC, 18 December 1986, L358.
8
8. Atzori, C., F. Agostini, A. Angeli, A. Mainini, V. Micheli, and A. Cargnel. 1999. P. carinii host specificity: attempt of cross infections with human derived strains in rats. J. Eukaryot. Microbiol. 46(Suppl.):112.
9
9. Beard, C. B., V. M. Jennings, G. W. Teague, J. L. Carter, J. Mabry, H. Moura, G. S. Vivesvera, W. E. Collins, and T. R. Navin. 1999. Experimental inoculation of immunosuppressed owl monkeys with Pneumocystis carinii f. sp. hominis. J. Eukaryot. Microbiol. 46(Suppl.):113-115.
10
10. Dei-Cas, E., E. Mazars, E. M. Aliouat, G. Nevez, J. C. Cailliez, and D. Camus. 1998. The host-specificity of Pneumocystis carinii. J. Mycol. Med. 8:1-6.
11
11. Dei-Cas, E., M. Brun-Pascaud, V. Bille-Hansen, A. Allaert, and E. M. Aliouat. 1998. Animal models of pneumocystosis. FEMS Immunol. Med. Microbiol. 22:163-168.[CrossRef][Medline]
12
12. Dei-Cas, E. 2000. Pneumocystis infections: the iceberg? Med. Mycol. 38(Suppl. 1):23-32.
13
13. Demanche, C., M. Berthelemy, T. Petit, B. Polack, A. E. Wakefield, E. Dei-Cas, and J. Guillot. 2001. Phylogeny of Pneumocystis carinii from 18 primate species confirms host specificity and suggests co-evolution. J. Clin. Microbiol. 39:2126-2133.[Abstract/Free Full Text]
14
14. Dumoulin, A., E. Mazars, N. Seguy, D. Gargallo-Viola, S. Vargas, J. C. Cailliez, E. M. Aliouat, and E. Dei-Cas. 2000. Immunocompetent contacts of Pneumocystis carinii-infected hosts can potentially transmit the disease to susceptible hosts. Eur. J. Clin. Microbiol. Infect. Dis. 19:671-678.[CrossRef][Medline]
15
15. Durand-Joly, I., A. E. Wakefield, R. J. Palmer, C. M. Denis, C. Creusy, L. Fleurisse, I. Ricard, J. P. Gut, and E. Dei-Cas. 2000. Ultrastructural and molecular characterization of Pneumocystis carinii isolated from a rhesus monkey (Macaca mulatta). Med. Mycol. 38:61-72.[Medline]
16
16. European Concerted Action on Pneumocystis carinii. 1996. In vitro systems in Pneumocystis research. Parasitol. Today 12:245-249.
17
17. Fourmaintraux, S. 1997. Forte hétérogénéité de Pneumocystis carinii chez les micro-mammifères sauvages européens et absence apparente de P. carinii sp. f. hominis. Ph.D. thesis. University of Lille-2, Lille, France.
18
18. Furuta, T., and K. Ueda. 1987. Intra- and inter-species transmission and antigenic difference of Pneumocystis carinii derived from rat and mouse. Jpn. J. Exp. Med. 57:11-17.[Medline]
19
19. Furuta, T., M. Fujita, R. Mukai, I. Sakakibara, T. Sata, K. Miki, M. Hayami, S. Kojima, and Y. Yoshikawa. 1993. Severe pulmonary pneumocystosis in simian acquired immunodeficiency syndrome induced by simian immunodeficiency virus--its characterization by the polymerase chain reaction method and failure of experimental transmission to immunodeficient animals. Parasitol. Res. 79:624-628.[CrossRef][Medline]
20
20. Gigliotti, F., A. G. Harmsen, C. G. Haidaris, and P. J. Haidaris. 1993. Pneumocystis carinii is not universally transmissible between mammalian species. Infect. Immun. 61:2886-2890.[Abstract/Free Full Text]
21
21. Mazars, E., and E. Dei-Cas. 1998. Epidemiological and taxonomic impact of Pneumocystis biodiversity. FEMS Immunol. Med. Microbiol. 22:75-80.[CrossRef][Medline]
22
22. Nielsen, M. H., O. P. Settnes, E. M. Aliouat, J. C. Cailliez, and E. Dei-Cas. 1998. Different ultrastructural morphology of Pneumocystis carinii derived from mice, rats, and rabbits. APMIS 106:771-779.[Medline]
23
23. Sethi, K. K. 1992. Multiplication of human-derived Pneumocystis carinii in severe combined immunodeficient (SCID) mice. Experientia 48:63-66.[CrossRef][Medline]
24
24. Vargas, S. L., W. T. Hughes, M. E. Santolaya, C. A. Ponce, A. V. Ulloa, C. E. Cabrera, and F. Gigliotti. 2001. Search for primary infection by Pneumocystis carinii in a cohort of normal healthy infants. Clin. Infect. Dis. 20:306-309.[CrossRef]
25
25. Wakefield, A. E., F. J. Pixley, S. Banerji, K. Sinclair, R. F. Miller, E. R. Moxon, and J. M. Hopkin. 1990. Detection of Pneumocystis carinii with DNA amplification. Lancet 336:451-453.[CrossRef][Medline]
26
26. Wakefield, A. E., J. R. Stringer, E. Tamburrini, and E. Dei-Cas. 1998. Genetics, metabolism and host specificity of Pneumocystis carinii. Med. Mycol. 36(Suppl.):183-193.
27
27. Walzer, P. D. 1984. Experimental models of Pneumocystis carinii infection, p. 37-43. In L. S. Young (ed.), Pneumocystis carinii pneumonia, 1st ed. Marcel Dekker, Inc., New York, N.Y.
28
28. Walzer, P. D., V. Schnelle, D. Armstrong, and P. P. Rosen. 1977. Nude mouse: a new experimental model for Pneumocystis carinii infection. Science 197:177-179.[Abstract/Free Full Text]

---

Journal of Clinical Microbiology, May 2002, p. 1862-1865, Vol. 40, No. 5
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.5.1862-1865.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

This article has been cited by other articles:

• Keely, S. P., Fischer, J. M., Cushion, M. T., Stringer, J. R. (2004). Phylogenetic identification of Pneumocystis murina sp. nov., a new species in laboratory mice. Microbiology 150: 1153-1165 [Abstract] [Full Text]  
• Chabe, M., Vargas, S. L., Eyzaguirre, I., Aliouat, E. M., Follet-Dumoulin, A., Creusy, C., Fleurisse, L., Recourt, C., Camus, D., Dei-Cas, E., Durand-Joly, I. (2004). Molecular typing of Pneumocystis jirovecii found in formalin-fixed paraffin-embedded lung tissue sections from sudden infant death victims. Microbiology 150: 1167-1172 [Abstract] [Full Text]  
• Schaffzin, J. K., Stringer, J. R. (2004). Expression of the Pneumocystis carinii major surface glycoprotein epitope is correlated with linkage of the cognate gene to the upstream conserved sequence locus. Microbiology 150: 677-686 [Abstract] [Full Text]  
• Gigliotti, F., Harmsen, A. G., Wright, T. W. (2003). Characterization of Transmission of Pneumocystis carinii f. sp. muris through Immunocompetent BALB/c Mice. Infect. Immun. 71: 3852-3856 [Abstract] [Full Text]  
• Totet, A., Pautard, J.-C., Raccurt, C., Roux, P., Nevez, G. (2003). Genotypes at the Internal Transcribed Spacers of the Nuclear rRNA Operon of Pneumocystis jiroveci in Nonimmunosuppressed Infants without Severe Pneumonia. J. Clin. Microbiol. 41: 1173-1180 [Abstract] [Full Text]  
• Nevez, G., Totet, A., Jounieaux, V., Schmit, J.-L., Dei-Cas, E., Raccurt, C. (2003). Pneumocystis jiroveci Internal Transcribed Spacer Types in Patients Colonized by the Fungus and in Patients with Pneumocystosis from the Same French Geographic Region. J. Clin. Microbiol. 41: 181-186 [Abstract] [Full Text]  

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Durand-Joly, I. Articles by Dei-Cas, E. Search for Related Content PubMed PubMed Citation Articles by Durand-Joly, I. Articles by Dei-Cas, E.